Dr Ashish Kumar is a Professor and Senior Consultant at the Institute of Liver, Gastroenterology, & Panceatico-Biliary Sciences, Ganga Ram Institute for Postgraduate Medical Education & Research (GRIPMER) of Sir Ganga Ram Hospital, New Delhi, India. He completed his Gastroenterology training from the Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India in 2004. Subsequently, he worked under the mentorship of Prof Shiv Kumar Sarin for 5 years in his unit in various capacities including at the Institute of Liver & Biliary Sciences (ILBS), New Delhi, India. He has been a visiting fellow at the National Cancer Center, Japan and the University of California, San Francisco, USA. His research areas include mainly hepatocellular carcinoma, portal hypertension, acute-on-chronic-liver failure, and stem cells for liver diseases. He has over 150 publications mostly in international journals, including Gastroenterology, Annals of Internal Medicine, and Gut. He is the coordinator and the lead author of the Indian Consensus on Treatment of Liver Cancer under the aegis of Indian National Association for the Study of the Liver (INASL). He has been a Governing Council Member of the INASL and Taskforce member on Hepatitis B and was instrumental in publishing various INASL Guidelines and also a member of many APASL working groups. His paper on HVPG-Fibroscan correlation was awarded the Best Paper Award by the GRIPMER. He also received the India International Healthcare Award for being The Most Promising Gastroenterologist of the Year 2018 of Delhi.

Dr. Kun Deng is a Professor and Chief Technician at the Third Affiliated Hospital of Chongqing Medical University, where he also serves as Director of the Department of Medical Laboratory and Deputy Director of the Center for Innovation and Technology. His research focuses on pioneering technologies for tumor liquid biopsy and clinical translation of novel diagnostic platforms.
He has published extensively in leading international journals, including Nature Medicine and Biosensors and Bioelectronics, as first or corresponding author. Dr. Deng is the principal investigator on three projects funded by the National Natural Science Foundation of China (NSFC), in addition to grants from the Chongqing Natural Science Foundation and key research initiatives supported by the Chongqing Health Commission.
Professional Affiliations

• Member, Chinese Expert Group on Tumor Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
• Committee Member, Laboratory Medicine Branch, Chinese Medical Association
• Member, Clinical Molecular Diagnostics Group, Laboratory Physician Branch, Chinese Medical Doctor Association
• Deputy Chair, Medical Laboratory Quality Management Committee, China Pharmaceutical Quality Management Association
• Deputy Chair, Laboratory Medicine Branch, Chongqing Medical Association
• Council Member, Chongqing Association of Young Leading Science and Technology Talents
• Member, Expert Advisory Committee on Precision Medicine Technology and Industry Development, Chongqing

PHAM THI THU THUY's has a distinguished career in hepatology and she holds positions as Chief of the hepatology department at Medic Medical Center and Head of the Department of Internal Medicine at Phan Chu Trinh Medical University. She is also Vice President of both The Vietnamese and HCMC associations for the study of liver diseases. Her extensive education includes a medical degree, an internship at Cho Ray Hospital, and specialized courses and a PhD in hepatology from various international institutions. She is a member of several prominent international medical societies, including AASLD, EASL, AGA, and APASL. Her scientific activities involve teaching, international investigations, and reviewing for prestigious journals. Dr. Thuy has an impressive publication record, with approximately 80 topics in hepatology in Vietnam and over 40 international publications, including numerous posters and presentations at major congresses, many of which have received awards. Her research focuses on hepatitis B and C, liver disease biomarkers, and multi-cancer detection.

Dr. Chan is a distinguished Professor of Medicine and Director of the Division of Gastroenterology and Hepatology at the University of Malaya, UMMC, and UMSC. A graduate with distinction (2005), he holds an MRCP (UK) and a Ph.D. (2015) focusing on MAFLD.
His significant impact is rooted in his research on MAFLD, where his Ph.D. work described a two-step non-invasive assessment of liver fibrosis that forms the basis of current national and international guidelines. He is a lead author for the MSGH Consensus Statements on MAFLD and contributes to key national and APASL clinical practice guidelines. His expertise is recognized globally, evidenced by his involvement in NASH clinical trials and his ranking among the top 2% of scientists worldwide in 2023 and 2024.
Dr. Chan is also a committed educator and leader, serving in executive roles for the MSGH and as a core member for Asian Pacific Digestive Week (APDW). Since 2023, he has convened the Young Clinician Investigator Programme at APDW. He has also served as an Associate Editor for the Journal of Gastroenterology and Hepatology and sits on the Editorial Boards of several international journals, actively training the next generation of specialists in gastroenterology and advanced therapeutic endoscopy.